scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00134-011-2248-7 |
P953 | full work available at URL | http://link.springer.com/article/10.1007/s00134-011-2248-7/fulltext.html |
http://link.springer.com/content/pdf/10.1007/s00134-011-2248-7 | ||
http://link.springer.com/content/pdf/10.1007/s00134-011-2248-7.pdf | ||
P698 | PubMed publication ID | 21647720 |
P5875 | ResearchGate publication ID | 51197824 |
P50 | author | Harald Herkner | Q92095804 |
P2093 | author name string | Peter Schellongowski | |
Nikolaus Kneidinger | |||
Valentin Fuhrmann | |||
Maximilian Schöniger-Hekele | |||
Gottfried Heinz | |||
Peter Schenk | |||
Christian Madl | |||
Bernhard Angermayr | |||
Mariam Nikfardjam | |||
Anja Bojic | |||
P2860 | cites work | Shock liver | Q93653302 |
The epidemiology of sepsis in the United States from 1979 through 2000 | Q29547760 | ||
Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation | Q30479924 | ||
Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis | Q33237411 | ||
Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases | Q34282198 | ||
Ischemic hepatitis: widening horizons | Q34450559 | ||
Ischemic hepatitis: clinical and laboratory observations of 34 patients | Q34469212 | ||
Liver in sepsis and systemic inflammatory response syndrome | Q35040127 | ||
A prospective study of the causes of notably raised aspartate aminotransferase of liver origin | Q35355992 | ||
Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics | Q36029878 | ||
Hypoxic liver injury | Q36592583 | ||
The importance of immune dysfunction in determining outcome in acute liver failure | Q37272915 | ||
Hypoxic hepatitis - epidemiology, pathophysiology and clinical management | Q37723358 | ||
Extreme serum elevations of aspartate aminotransferase | Q38508689 | ||
Direct effects of various catecholamines on liver circulation in dogs | Q39095756 | ||
Ischemic hepatitis: clinical presentation and pathogenesis | Q41758787 | ||
The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion | Q42855607 | ||
Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients | Q43947422 | ||
'Liver function tests' on the intensive care unit: a prospective, observational study | Q45033147 | ||
Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats | Q45045433 | ||
Mortality associated with ischaemic hepatitis | Q45176270 | ||
Negative impact of systemic catecholamine administration on hepatic blood perfusion after porcine liver transplantation | Q45235441 | ||
Catecholamines induce an inflammatory response in human hepatocytes | Q46630957 | ||
Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients | Q50736316 | ||
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies | Q53368936 | ||
Current epidemiology of septic shock: the CUB-Réa Network | Q53924344 | ||
Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury. | Q54539596 | ||
Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats | Q63859559 | ||
Compensated cardiogenic shock: a subset with damage limited to liver and kidneys. The possible salutary effect of low-dose dopamine | Q69054100 | ||
Ischemic hepatitis: clinical features, diagnosis and prognosis | Q70975008 | ||
Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow | Q72631908 | ||
Hepatic microvascular regulatory mechanisms. I. Adrenergic mechanisms | Q72884301 | ||
Xanthine oxidase mediates myocardial injury after hepatoenteric ischemia-reperfusion | Q73454346 | ||
Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients | Q78500306 | ||
Incidence and prognosis of early hepatic dysfunction in critically ill patients--a prospective multicenter study | Q79862239 | ||
Hepatopulmonary syndrome in patients with hypoxic hepatitis | Q79871763 | ||
Hypoxic hepatopathy: pathophysiology and prognosis | Q80625175 | ||
Real-time assessment of hepatic function is related to clinical outcome in critically ill patients after polytrauma | Q80814220 | ||
Declining mortality in patients with acute renal failure, 1988 to 2002 | Q82635542 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hypoxia | Q105688 |
intensive care unit | Q5094647 | ||
P304 | page(s) | 1302-1310 | |
P577 | publication date | 2011-06-07 | |
P1433 | published in | Intensive Care Medicine | Q15749164 |
P1476 | title | Impact of hypoxic hepatitis on mortality in the intensive care unit | |
P478 | volume | 37 |
Q41062798 | A prospective study on the causes of notably raised alanine aminotransferase (ALT). |
Q44656794 | Abnormal liver function tests in the intensive care unit |
Q42265663 | Acute Liver Impairment in a Young, Healthy Athlete: Hypoxic Hepatitis and Rhabdomyolysis following Heat Stroke. |
Q58612062 | Acute liver dysfunction after cardiac arrest |
Q38590747 | Cholestatic liver (dys)function during sepsis and other critical illnesses |
Q43156606 | Clinical features of ischemic hepatitis caused by shock with four different types: a retrospective study of 328 cases |
Q86701754 | Clinical impact of arterial ammonia levels in ICU patients with different liver diseases |
Q35860793 | Early Hepatic Dysfunction Is Associated with a Worse Outcome in Patients Presenting with Acute Respiratory Distress Syndrome: A Post-Hoc Analysis of the ACURASYS and PROSEVA Studies |
Q33753529 | Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test |
Q38449587 | Extracorporeal therapy of patients with liver disease in the intensive care unit |
Q28078274 | Hypoxic Hepatitis: A Review and Clinical Update |
Q37958085 | Hypoxic hepatitis |
Q41997953 | Hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes |
Q47133334 | Impact of dynamic changes of elevated bilirubin on survival in patients on veno-arterial extracorporeal life support for acute circulatory failure |
Q40073396 | Impact of perioperative liver dysfunction on in-hospital mortality and long-term survival in infective endocarditis patients. |
Q38383749 | Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock |
Q55500120 | Increased circulating microRNA-122 is associated with mortality and acute liver injury in the acute respiratory distress syndrome. |
Q54974139 | Ischemic Hepatitis - Intercorrelated Pathology. |
Q47611244 | Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis |
Q40945062 | LiFe: a liver injury score to predict outcome in critically ill patients |
Q92872800 | Liver Injury and Failure in Critical Illness |
Q36679145 | Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgery |
Q40908595 | Low serum albumin and advanced age predict early mortality in Asian patients with extreme elevations of serum aminotransferase |
Q41334461 | Low serum albumin predicts early mortality in patients with severe hypoxic hepatitis |
Q26863639 | Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness |
Q38676886 | Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC |
Q40620591 | Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit |
Q42371761 | Outcome of in- and out-of-hospital cardiac arrest survivors with liver cirrhosis |
Q26738929 | Pancreatic injury in patients with septic shock: A literature review |
Q36166232 | Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome |
Q60916641 | Prevalence and Prognostic Value of Abnormal Liver Test Results in Critically Ill Children and the Impact of Delaying Parenteral Nutrition |
Q42820143 | Preventive effects of dexmedetomidine on the liver in a rat model of acid-induced acute lung injury. |
Q36077343 | Prognostic Impact of Combined Contrast-Induced Acute Kidney Injury and Hypoxic Liver Injury in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results from INTERSTELLAR Registry. |
Q36348416 | Prognostic impact of ICG-PDR in patients with hypoxic hepatitis |
Q53655924 | The neuroimmune guidance cue netrin-1 controls resolution programs and promotes liver regeneration. |
Q90048333 | The role of bilirubin to albumin ratio as a predictor for mortality in critically ill patients without existing liver or biliary tract disease |
Q49506270 | The ten tips to manage critically ill patients with acute-on-chronic liver failure |
Q35795306 | Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals. |
Q89319923 | [Acute liver failure] |
Q91911520 | [Acute liver failure] |
Q88019229 | [Extracorporeal therapies in hepatic diseases] |
Q90185051 | [Hepatic dysfunction in patients with cardiogenic shock] |
Q85370747 | [Hepatocardiac disorders : Interactions between two organ systems] |
Q88221802 | [Monitoring of liver function in the critically ill] |
Q87764442 | [Shock liver and cholestatic liver in critically ill patients] |
Q87676192 | [Statin therapy as a protective factor regarding development of hypoxic hepatitis] |
Search more.